Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mono PharmacareNSE:MONOPHARMA 9 Days Inventory is 158.01 as of Sep. 2025, which is 35% above its 10-year median of 117.03. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 494 Healthcare Providers & Services companies, Mono Pharmacare ranks worse than 89.27% on this metric.
The historical rank and industry rank for Mono Pharmacare's Days Inventory or its related term are showing as below:
NSE:MONOPHARMA'
s Days Inventory Range Over the Past 10 Years
Min: 46.58 Med: 117.03 Max: 139.71
Current: 139.71
During the past 5 years, Mono Pharmacare's highest Days Inventory was 139.71. The lowest was 46.58. And the median was 117.03.
NSE:MONOPHARMA's Days Inventory is ranked worse than 89.27% of 494
companies
in the Healthcare Providers & Services industry
Industry Median: 29.395
vs NSE:MONOPHARMA: 139.71
Mono Pharmacare's Days Inventory
increased
from Sep. 2024 (103.53) to Sep. 2025 (158.01).
It might indicate that Mono Pharmacare's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Mono Pharmacare's Inventory Turnover for the
six
months ended in Sep. 2025 was 1.15.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mono Pharmacare's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 0.81.
Mono Pharmacare (NSE:MONOPHARMA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Mono Pharmacare's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Mono Pharmacare's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Mono Pharmacare Days Inventory Related Terms
Mono Pharmacare Days Inventory Historical Data
* Premium members only.
The historical data trend for Mono Pharmacare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mono Pharmacare Days Inventory Competitor Comparison
For the Pharmaceutical Retailers subindustry, Mono Pharmacare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mono Pharmacare Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Mono Pharmacare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mono Pharmacare (NSE:MONOPHARMA) has a Days Inventory of 158.01 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mono Pharmacare and its competitors. This is 35% above median its historical median of 117.03. Over the past decade, Mono Pharmacare's Days Inventory has ranged from 46.58 to 139.71. According to the industry distribution chart, Mono Pharmacare ranks #441 out of 494 companies in the Healthcare Providers & Services industry, placing it in the top 89.3%.
Is Mono Pharmacare's Days Inventory too high?
Mono Pharmacare's current Days Inventory of 158.01 is 35% above median its 10-year median of 117.03. Over the past 10 years, this metric has ranged from a low of 46.58 to a high of 139.71. The Healthcare Providers & Services industry median Days Inventory is 29.40. Mono Pharmacare's value of 158.01 is 437.5% above this industry median. Based on the distribution chart, Mono Pharmacare ranks #441 out of 494 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mono Pharmacare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's Days Inventory compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Mono Pharmacare ranks #441 out of 494 companies for Days Inventory. This places Mono Pharmacare in the lower half of its industry. The industry median Days Inventory is 29.40. Mono Pharmacare's value of 158.01 is 437.5% above this benchmark. Historically, Mono Pharmacare's own Days Inventory has ranged from 46.58 to 139.71 over the past decade. While the company's 10-year median is 117.03 vs. the industry median of 29.40, Mono Pharmacare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.40, based on 494 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mono Pharmacare's current Days Inventory of 158.01 is 437.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Mono Pharmacare and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mono Pharmacare's current Days Inventory is 158.01, which is 35% above median its own 10-year median of 117.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current Days Inventory of 158.01. The current Days Inventory is 158.01, which is 35% above median its 10-year median of 117.03 and 437.5% above the Healthcare Providers & Services industry median of 29.40. Mono Pharmacare's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current Days Inventory is 158.01 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
9GF Score
Get the complete analysis for NSE:MONOPHARMA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MONOPHARMA has been successfully added to your 
